Renalytix Ai Stock Shares Owned By Institutions

RNLX Stock

USD 0.46 0.01 2.87%

Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Renalytix AI Company Shares Owned By Institutions Analysis

Renalytix's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Shares Held by Institutions

Funds and Banks

+

Firms

More About Shares Owned By Institutions | All Equity Analysis

Current Renalytix Shares Owned By Institutions

5.52 %

Most of Renalytix's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Renalytix Shares Owned By Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Renalytix is extremely important. It helps to project a fair market value of Renalytix Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Renalytix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Renalytix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Renalytix's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Accounts Payable	Short Term Investments	Deferred Long Term Liab	Capital Stock	Intangible Assets	Property Plant Equipment	Long Term Debt	Current Deferred Revenue
Total Assets		0.96	0.89	-0.92	-0.39	0.89	0.64	0.99	0.51	0.98	0.96	0.52	0.82	0.45	0.78	0.82	0.62	-0.55	0.93	0.5	-0.47
Total Stockholder Equity	0.96		0.95	-0.96	-0.16	0.77	0.43	0.96	0.28	0.94	0.98	0.3	0.64	0.25	0.86	0.66	0.4	-0.32	0.86	0.27	-0.24
Net Tangible Assets	0.89	0.95		-0.99	0.01	0.74	0.24	0.87	0.1	0.9	0.96	0.11	0.49	0.02	0.94	0.55	0.27	-0.13	0.81	0.09	-0.04
Net Debt	-0.92	-0.96	-0.99		0.12	-0.82	-0.35	-0.9	-0.21	-0.95	-0.98	-0.22	-0.57	-0.13	-0.95	-0.6	-0.38	0.24	-0.86	-0.2	0.16
Retained Earnings	-0.39	-0.16	0.01	0.12		-0.64	-0.91	-0.36	-0.94	-0.41	-0.23	-0.94	-0.73	-0.89	0.01	-0.62	-0.85	0.91	-0.48	-0.95	0.97
Net Receivables	0.89	0.77	0.74	-0.82	-0.64		0.76	0.84	0.68	0.94	0.85	0.68	0.84	0.57	0.72	0.83	0.8	-0.69	0.92	0.67	-0.65
Total Liab	0.64	0.43	0.24	-0.35	-0.91	0.76		0.62	0.98	0.63	0.48	0.98	0.88	0.92	0.16	0.85	0.9	-0.98	0.71	0.97	-0.97
Net Invested Capital	0.99	0.96	0.87	-0.9	-0.36	0.84	0.62		0.49	0.96	0.94	0.5	0.82	0.45	0.74	0.82	0.6	-0.54	0.9	0.48	-0.45
Short Long Term Debt	0.51	0.28	0.1	-0.21	-0.94	0.68	0.98	0.49		0.51	0.35	1.0	0.79	0.88	0.02	0.75	0.84	-0.99	0.63	1.0	-0.98
Total Current Assets	0.98	0.94	0.9	-0.95	-0.41	0.94	0.63	0.96	0.51		0.98	0.52	0.77	0.42	0.84	0.8	0.62	-0.54	0.96	0.5	-0.46
Net Working Capital	0.96	0.98	0.96	-0.98	-0.23	0.85	0.48	0.94	0.35	0.98		0.36	0.64	0.26	0.89	0.68	0.44	-0.38	0.93	0.34	-0.29
Short Term Debt	0.52	0.3	0.11	-0.22	-0.94	0.68	0.98	0.5	1.0	0.52	0.36		0.8	0.88	0.03	0.76	0.85	-0.99	0.64	1.0	-0.98
Common Stock	0.82	0.64	0.49	-0.57	-0.73	0.84	0.88	0.82	0.79	0.77	0.64	0.8		0.78	0.37	0.94	0.91	-0.85	0.76	0.79	-0.81
Accounts Payable	0.45	0.25	0.02	-0.13	-0.89	0.57	0.92	0.45	0.88	0.42	0.26	0.88	0.78		0.0	0.74	0.88	-0.9	0.45	0.88	-0.95
Short Term Investments	0.78	0.86	0.94	-0.95	0.01	0.72	0.16	0.74	0.02	0.84	0.89	0.03	0.37	0.0		0.42	0.25	-0.04	0.71	0.01	0.0
Deferred Long Term Liab	0.82	0.66	0.55	-0.6	-0.62	0.83	0.85	0.82	0.75	0.8	0.68	0.76	0.94	0.74	0.42		0.88	-0.83	0.81	0.74	-0.74
Capital Stock	0.62	0.4	0.27	-0.38	-0.85	0.8	0.9	0.6	0.84	0.62	0.44	0.85	0.91	0.88	0.25	0.88		-0.89	0.61	0.84	-0.89
Intangible Assets	-0.55	-0.32	-0.13	0.24	0.91	-0.69	-0.98	-0.54	-0.99	-0.54	-0.38	-0.99	-0.85	-0.9	-0.04	-0.83	-0.89		-0.64	-0.98	0.97
Property Plant Equipment	0.93	0.86	0.81	-0.86	-0.48	0.92	0.71	0.9	0.63	0.96	0.93	0.64	0.76	0.45	0.71	0.81	0.61	-0.64		0.62	-0.54
Long Term Debt	0.5	0.27	0.09	-0.2	-0.95	0.67	0.97	0.48	1.0	0.5	0.34	1.0	0.79	0.88	0.01	0.74	0.84	-0.98	0.62		-0.98
Current Deferred Revenue	-0.47	-0.24	-0.04	0.16	0.97	-0.65	-0.97	-0.45	-0.98	-0.46	-0.29	-0.98	-0.81	-0.95	0.0	-0.74	-0.89	0.97	-0.54	-0.98

Click cells to compare fundamentals

Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Competition

Predict Renalytix

Based on the latest financial disclosure, 5.52% of Renalytix AI are shares owned by institutions. This is 87.63% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 85.92% higher than that of the company.

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

All Next

Launch Module

Renalytix Fundamentals

	Return On Equity	-10.73
	Return On Asset	-0.86
	Operating Margin	(11.47) %
	Current Valuation	71.66 M
	Shares Outstanding	77.18 M
	Shares Owned By Insiders	4.85 %
	Shares Owned By Institutions	5.52 %
	Number Of Shares Shorted	446.61 K
	Price To Book	20.68 X
	Price To Sales	22.89 X
	Revenue	3.4 M
	Gross Profit	720 K
	EBITDA	(35.5 M)
	Net Income	(46.22 M)
	Cash And Equivalents	32.36 M
	Cash Per Share	0.89 X
	Total Debt	12.15 M
	Debt To Equity	0.01 %
	Current Ratio	2.48 X
	Book Value Per Share	(0.09) X
	Cash Flow From Operations	(32.67 M)
	Short Ratio	1.63 X
	Earnings Per Share	(0.76) X
	Target Price	3.5
	Beta	1.98
	Market Capitalization	33.47 M
	Total Asset	42.12 M
	Retained Earnings	(99.18 M)
	Working Capital	12.2 M
	Net Asset	42.12 M

About Renalytix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Renalytix AI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix AI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
GM	General Motors
GM	General Motors

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC